Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Endokrynologia Polska|September 29, 2006
[Recombinant human TSH stimulation in radioiodine treatment of disseminated differentiated thyroid cancer--update of current and our own experiences]Kornelia Hasse-Lazar, Daria Handkiewicz-Junak, Józef Roskosz, et al.
Endokrynologia Polska|December 4, 2025
Real-world study of lenvatinib in patients with radioiodine‑refractory thyroid cancer treated in a tertiary reference centerJolanta Krajewska, Barbara Jarząb, Agata Wilk, et al.
Current Oncology (Toronto, Ont.)|July 26, 2024
Stereotactic Body Radiation Therapy for Symptomatic Pancreatic Insulinoma: Two-Case Report and Literature ReviewAgnieszka Namysl-Kaletka, Jerzy Wydmanski, Iwona Debosz-Suwinska, et al.
Endokrynologia Polska|November 4, 2009
Long-term survival and nearly asymptomatic course of carcinoid tumour with multiple metastases (treated by surgery, chemotherapy, (90)Y-DOTATATE, and LAR octreotide analogue): a case reportMarcin Kałuzny, Marek Bolanowski, Małgorzata Sukiennik-Kujawa, et al.
European Thyroid Journal|January 4, 2022
2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?Furio Pacini, Dagmar Fuhrer, Rossella Elisei, et al.
European Journal of Endocrinology|October 2, 2015
Recombinant human thyrotropin preparation for adjuvant radioiodine treatment in children and adolescents with differentiated thyroid cancerDaria Handkiewicz-Junak, Tomasz Gawlik, Jozef Rozkosz, et al.
Endokrynologia Polska|July 11, 2008
[131I-MIBG therapy in the treatment of pheochromocytoma in children--own experiences]Kornelia Hasse-Lazar, Jolanta Krajewska, Ewa Paliczka-Cieślik, et al.
Frontiers in Oncology|December 19, 2024
The role of FDG PET assessment in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 inhibitors in the second-line settingMarcin Kubeczko, Anna Polakiewicz-Gilowska, Andrea D'Amico, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 18, 2018
EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclidesDaria Handkiewicz-Junak, Thorsten D Poeppel, Lisa Bodei, et al.
Frontiers in Endocrinology|October 30, 2020
Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better SurvivalJolanta Krajewska, Aleksandra Kukulska, Malgorzata Oczko-Wojciechowska, et al.
Pageof 8